lignocaine / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 7 Diseases   124 Trials   124 Trials   723 News 


«12...234567891011121314»
  • ||||||||||  dexamethasone / Generic mfg., lignocaine / Generic mfg.
    Enrollment open, Trial completion date, Trial primary completion date:  Dexamethasone vs Bicarbonate to Intracuff Lignocaine 2% in General Anaesthesia (clinicaltrials.gov) -  Jul 31, 2019   
    P4,  N=100, Recruiting, 
    Not yet recruiting --> Recruiting | Trial completion date: Mar 2019 --> Aug 2019 | Trial primary completion date: Mar 2019 --> Jul 2019
  • ||||||||||  NN1213 / Novo Nordisk, Chirocaine (levobupivacaine) / Purdue, AbbVie
    Trial completion, Enrollment change:  Decision Support for Intraoperative Low Blood Pressure (clinicaltrials.gov) -  May 16, 2019   
    P=N/A,  N=22435, Completed, 
    Not yet recruiting --> Recruiting | Trial completion date: Mar 2019 --> Aug 2019 | Trial primary completion date: Mar 2019 --> Jul 2019 Active, not recruiting --> Completed | N=16000 --> 22435
  • ||||||||||  lignocaine / Generic mfg.
    New trial:  POSTrepsils: Does Strepsils (clinicaltrials.gov) -  May 8, 2019   
    P=N/A,  N=60, Recruiting, 
  • ||||||||||  NN1213 / Novo Nordisk, Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
    Enrollment change, Trial completion date, Trial termination, Trial primary completion date:  Injecting Botulinum Toxin A Underneath the Skin to Treat Spinal Cord Pain in Patients With Spinal Cord Injury (clinicaltrials.gov) -  Apr 9, 2019   
    P2,  N=8, Terminated, 
    Active, not recruiting --> Completed | N=16000 --> 22435 N=32 --> 8 | Trial completion date: Feb 2019 --> Jul 2018 | Recruiting --> Terminated | Trial primary completion date: Feb 2019 --> Jul 2018; funding not available to continue
  • ||||||||||  lignocaine / Generic mfg.
    New P3 trial, Intubation:  Intravenous Lignocaine vs Placebo (clinicaltrials.gov) -  Dec 26, 2018   
    P3,  N=120, Completed, 
  • ||||||||||  esmolol / Generic mfg.
    Trial completion date, Trial primary completion date:  Intraoperative Lidocaine Infusion vs. Esmolol Infusion for Postoperative Analgesia in Laparoscopic Cholecystectomy (clinicaltrials.gov) -  Nov 30, 2018   
    P4,  N=90, Completed, 
    Recruiting --> Active, not recruiting | Trial completion date: Dec 2021 --> Dec 2023 | Trial primary completion date: Dec 2019 --> Dec 2023 Trial completion date: Aug 2015 --> Apr 2016 | Trial primary completion date: Aug 2015 --> Feb 2016
  • ||||||||||  lignocaine / Generic mfg.
    Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  CRISP: Transcricoid Injection vs. Spray as You go Method for Local Anaesthesia During Bronchoscopy (clinicaltrials.gov) -  Nov 26, 2018   
    P=N/A,  N=500, Completed, 
    Trial completion date: Aug 2015 --> Apr 2016 | Trial primary completion date: Aug 2015 --> Feb 2016 Recruiting --> Completed | N=150 --> 500 | Trial completion date: Dec 2017 --> Mar 2018 | Trial primary completion date: Dec 2017 --> Mar 2018
  • ||||||||||  lignocaine / Generic mfg.
    Enrollment open, Trial completion date, Trial initiation date, Trial primary completion date:  Intravenous and Intraperitoneal Lignocaine for Perioperative Analgesia in Laparoscopic Colon Resections (clinicaltrials.gov) -  Oct 17, 2018   
    P4,  N=60, Recruiting, 
    Recruiting --> Completed | N=150 --> 500 | Trial completion date: Dec 2017 --> Mar 2018 | Trial primary completion date: Dec 2017 --> Mar 2018 Trial completion date: Dec 2018 --> Dec 2019 | Initiation date: Dec 2017 --> Aug 2018 | Trial primary completion date: Dec 2018 --> Dec 2019 | Not yet recruiting --> Recruiting
  • ||||||||||  lignocaine / Generic mfg.
    Trial primary completion date:  Subcutaneous Lidocaine For Cancer-Related Pain (clinicaltrials.gov) -  Oct 15, 2018   
    P2/3,  N=50, Suspended, 
    Trial completion date: Dec 2018 --> Dec 2019 | Initiation date: Dec 2017 --> Aug 2018 | Trial primary completion date: Dec 2018 --> Dec 2019 | Not yet recruiting --> Recruiting Trial primary completion date: Aug 2018 --> Dec 2017
  • ||||||||||  NN1213 / Novo Nordisk, Chirocaine (levobupivacaine) / Purdue, AbbVie
    Enrollment closed, Trial completion date, Trial primary completion date:  Decision Support for Intraoperative Low Blood Pressure (clinicaltrials.gov) -  Oct 12, 2018   
    P=N/A,  N=16000, Active, not recruiting, 
    Trial primary completion date: Aug 2018 --> Dec 2017 Recruiting --> Active, not recruiting | Trial completion date: Aug 2018 --> Dec 2018 | Trial primary completion date: Jul 2018 --> Dec 2017
  • ||||||||||  lignocaine / Generic mfg.
    Enrollment change, Trial withdrawal:  Effect of 2% Lignocaine Solution in Pain During Removal of Nasal Pack (clinicaltrials.gov) -  Sep 24, 2018   
    P=N/A,  N=0, Withdrawn, 
    Recruiting --> Active, not recruiting | Trial completion date: Aug 2018 --> Dec 2018 | Trial primary completion date: Jul 2018 --> Dec 2017 N=60 --> 0 | Recruiting --> Withdrawn
  • ||||||||||  Chirocaine (levobupivacaine) / Purdue, AbbVie
    Enrollment change, Trial withdrawal:  Quadratus Lumborum Block for Percutaneous Nephrostomy (clinicaltrials.gov) -  Apr 10, 2018   
    P4,  N=0, Withdrawn, 
    Active, not recruiting --> Completed N=40 --> 0 | Not yet recruiting --> Withdrawn
  • ||||||||||  lignocaine / Generic mfg.
    Enrollment open, Phase classification:  ultradian: Dynamic Hormone Diagnostics in Endocrine Disease (clinicaltrials.gov) -  Feb 23, 2018   
    P=N/A,  N=350, Recruiting, 
    N=40 --> 0 | Not yet recruiting --> Withdrawn Not yet recruiting --> Recruiting | Phase classification: P2/3 --> PN/A
  • ||||||||||  lignocaine / Generic mfg.
    Enrollment closed, Trial completion date, Trial primary completion date, Surgery:  Efficacy of Intravenous Lidocaine in the Operative Management of Thyroid Surgery With Intraoperative Nerve Monitoring (clinicaltrials.gov) -  Feb 22, 2018   
    P4,  N=66, Active, not recruiting, 
    Not yet recruiting --> Recruiting | Phase classification: P2/3 --> PN/A Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2017 --> Jul 2018 | Trial completion date: Dec 2017 --> Jul 2018
  • ||||||||||  lignocaine / Generic mfg.
    Trial suspension, Trial primary completion date:  Subcutaneous Lidocaine For Cancer-Related Pain (clinicaltrials.gov) -  Dec 4, 2017   
    P2/3,  N=50, Suspended, 
    Not yet recruiting --> Recruiting | Trial primary completion date: Jan 2018 --> Jun 2018 Recruiting --> Suspended | Trial primary completion date: Aug 2017 --> Aug 2018
  • ||||||||||  lignocaine / Generic mfg.
    Trial completion, Phase classification:  Paracervical Block Versus No Paracervical Block During IUD Insertion (clinicaltrials.gov) -  Dec 4, 2017   
    P4,  N=50, Completed, 
    Recruiting --> Suspended | Trial primary completion date: Aug 2017 --> Aug 2018 Not yet recruiting --> Completed | Phase classification: PN/A --> P4
  • ||||||||||  lignocaine / Generic mfg.
    Trial completion:  LIFE: 1% vs. 2 % Lignocaine for Flexible Bronchoscopy (clinicaltrials.gov) -  Aug 22, 2017   
    P=N/A,  N=500, Completed, 
    Initiation date: Jun 2017 --> Dec 2017 | Trial primary completion date: Aug 2018 --> Dec 2018 Recruiting --> Completed
  • ||||||||||  lignocaine / Generic mfg.
    Trial completion, Trial primary completion date, Endobronchial ultrasound:  1% vs. 2 % Lignocaine for Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (clinicaltrials.gov) -  Aug 22, 2017   
    P=N/A,  N=100, Completed, 
    Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2017 --> Sep 2018 Recruiting --> Completed | Trial primary completion date: Oct 2016 --> Jun 2017
  • ||||||||||  lidocaine topical / Generic mfg., lignocaine / Generic mfg.
    Trial completion:  Combination Analgesia for Neonatal Circumcision (clinicaltrials.gov) -  Jun 29, 2017   
    P3,  N=70, Completed, 
    Not yet recruiting --> Recruiting Active, not recruiting --> Completed